Patient-based Reliability of the Outcome Measures in Rheumatology (OMERACT) Ultrasound Scoring System for Salivary Gland Assessment in Patients with Sjögren's Syndrome
Overview
Authors
Affiliations
Background: To assess the reliability of the consensually agreed US definitions of major salivary gland lesions and the US scoring system for salivary gland assessment in patients with SS.
Methods: Nine experienced sonographers scanned and read the US images of both parotid glands (PGs) and submandibular glands (SMGs) in eight patients with primary and secondary SS in two rounds. A consensually agreed four-grade semi-quantitative scoring was applied in B-mode for morphological lesions: grade 0, normal; grade 1, mild inhomogeneity without anechoic or hypoechoic areas; grade 2, moderate inhomogeneity with focal anechoic or hypoechoic areas; grade 3, severe inhomogeneity with diffuse an- or hypoechoic areas occupying the entire gland or fibrous gland. The presence or absence of typical SS lesions, i.e. the Sjögren's signature, was scored binary. Intra- and interreader reliabilities were computed using weighted and unweighted Cohen's and Light's κ coefficients.
Results: The mean prevalence of grades 0-3 in PG were 43, 17, 23 and 31% and 28, 14, 33 and 32% for the SMGs, respectively. The weighted κ for intrareader reliability ranged from 0.44 to 1 for grading and 0.64 to 1 for the Sjögren's signature of PG and 0.59 to 1 and -0.09 to 0.6 for SMGs, respectively. The interreader reliability κ for grading in PG was 0.62 (95% CI 0.47, 0.74) and for Sjögren's signature it was 0.36 (95% CI 0, 0.43); in SMG it was 0.62 (95% CI 0.47, 0.72) and 0.03 (95% CI 0, 0.07) respectively.
Conclusions: The consensually agreed novel US scoring system for major salivary gland lesions showed substantial intra- and interreader reliability in patients with SS. The reliability of the Sjögren's signature was moderate.
Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology.
DIgnazio E, Corradini D, Cazenave T, Bixio R, Baldi C, Ubhi H Curr Rheumatol Rep. 2025; 27(1):20.
PMID: 40035992 PMC: 11880079. DOI: 10.1007/s11926-025-01186-9.
Bourgeois C, Sanchez Lucas M, Rodriguez Merlos P, Nieto-Gonzalez J, Alvaro-Gracia J, Molina-Collada J Clin Rheumatol. 2024; 43(12):3999-4001.
PMID: 39404965 DOI: 10.1007/s10067-024-07177-y.
Kahveci A, Gumustepe A, Sunar I, Ataman S BMC Endocr Disord. 2024; 24(1):199.
PMID: 39334038 PMC: 11430209. DOI: 10.1186/s12902-024-01740-z.
Hussein A, Gareeballah A, Hamd Z, Elzaki M, Ahmed Abouraida R, Eltahir M Radiol Case Rep. 2024; 19(11):5513-5518.
PMID: 39285982 PMC: 11403904. DOI: 10.1016/j.radcr.2024.07.196.
Opportunities in childhood Sjögren's disease: results from collaborative roundtable discussions.
Treemarcki E, Lieberman S, Basiaga M, Orrock J, Edens C, Thatayatikom A Rheumatology (Oxford). 2024; 63(12):e321-e324.
PMID: 38730544 PMC: 11637475. DOI: 10.1093/rheumatology/keae258.